Inovio Pharmaceuticals amends bylaws
- Effective October 6, 2026
- Added Article 12 for exclusive forum
- Delaware Chancery Court for fiduciary duty claims
Every EDGAR filing for INOVIO PHARMACEUTICALS, INC. (INO), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P., filed by
Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
Wendy L Yarno, insider filing for INO
Wendy L Yarno, reporting
Peter Kies, insider filing for INO
Peter Kies, reporting
Ownership stake disclosure by HIGHBRIDGE CAPITAL MANAGEMENT LLC (amended)
HIGHBRIDGE CAPITAL MANAGEMENT LLC, filed by
Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
Michael John Sumner, insider filing for INO
Michael John Sumner, reporting
Jacqueline Elizabeth Shea, insider filing for INO
Jacqueline Elizabeth Shea, reporting
Laurent Humeau, insider filing for INO
Laurent Humeau, reporting